| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mr. Jong-Hoon Lim CEO | KRX SM Exchange | KR7008930000 ISIN |
| KR Country | 475 Employees | 30 Mar 2026 Last Dividend | 27 Dec 2018 Last Split | - IPO Date |
Hanmi Science Co., Ltd., with its operational base in Seoul, South Korea, has been a notable figure in the pharmaceutical industry since its inception in 1973. Originally named Hanmi Holdings Co., Ltd., the company underwent a rebranding in March 2012 to emerge as Hanmi Science Co., Ltd. It operates on a global scale, providing a plethora of pharmaceutical products not just within Korea but also to an international clientele. The company's comprehensive reach spans from the development, manufacture, to the sale of varied pharmaceutical solutions. It leverages both online and offline channels, including pharmacies, to distribute its products, underscoring its robust presence in the pharmaceutical market.
At the heart of Hanmi Science's product line are its innovative offerings for managing diabetes and combating cancer. These critical therapeutic categories benefit from the company's continuous commitment to research and development, aiming to bring forward novel and effective treatment options.
Understanding the need for specialized medications across age groups, Hanmi Science produces a range of drugs for bowel preparation, aligning with procedural prerequisites, alongside cold medicines. These products are formulated to cater to both pediatric and adult patients, ensuring broad demographic applicability.
A staple in the fight against bacterial infections, cephalosporin antibiotics represent a crucial part of Hanmi Science's pharmaceutical repertoire. The company's antibiotics are pivotal in addressing various bacterial conditions, emphasizing its role in infectious disease management.
Expanding beyond pharmaceuticals, Hanmi Science also ventures into nutrition and wellness through its general and health functional foods, including soy milk. These products underscore the company's holistic approach to health, catering to the nutritional needs and well-being of its customers.
The manufacture and distribution of medical equipment further diversify Hanmi Science's offerings. This segment includes innovative solutions that support the healthcare industry, embodying the company's commitment to enhancing medical care quality and accessibility.
Embracing technological advancement, Hanmi Science offers automated drug management systems. These systems streamline pharmaceutical logistics and inventory management for healthcare providers, showcasing Hanmi Science's dedication to improving operational efficiency and patient care through innovation.